Humana Inc. $HUM Shares Sold by Tobam

Tobam lessened its stake in Humana Inc. (NYSE:HUM) by 48.6% in the fourth quarter, Holdings Channel reports. The fund owned 6,127 shares of the insurance provider’s stock after selling 5,783 shares during the quarter. Tobam’s holdings in Humana were worth $1,569,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the company. Invesco Ltd. boosted its stake in shares of Humana by 9.3% in the fourth quarter. Invesco Ltd. now owns 2,233,130 shares of the insurance provider’s stock valued at $571,972,000 after purchasing an additional 189,670 shares during the period. Corient Private Wealth LLC increased its stake in Humana by 329.3% during the 4th quarter. Corient Private Wealth LLC now owns 120,104 shares of the insurance provider’s stock worth $30,762,000 after buying an additional 92,125 shares during the period. Ameriflex Group Inc. acquired a new position in Humana in the 4th quarter worth $128,000. Naya Capital Management UK Ltd. lifted its holdings in Humana by 59.1% in the 4th quarter. Naya Capital Management UK Ltd. now owns 1,243,184 shares of the insurance provider’s stock worth $318,417,000 after buying an additional 461,563 shares in the last quarter. Finally, State of Tennessee Department of Treasury boosted its position in Humana by 221.9% in the 4th quarter. State of Tennessee Department of Treasury now owns 74,853 shares of the insurance provider’s stock valued at $19,172,000 after buying an additional 51,602 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently weighed in on the company. Wolfe Research upgraded Humana from a “hold” rating to a “strong-buy” rating in a research note on Thursday, June 4th. Needham & Company LLC initiated coverage on Humana in a research note on Wednesday, May 20th. They issued a “buy” rating on the stock. Oppenheimer raised Humana from an “outperform” rating to an “outperform” rating in a report on Wednesday, May 20th. Royal Bank Of Canada restated a “sector perform” rating on shares of Humana in a research note on Monday, June 1st. Finally, Piper Sandler restated a “neutral” rating and set a $254.00 price objective (up from $182.00) on shares of Humana in a report on Wednesday, May 13th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, sixteen have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $291.35.

Humana Price Performance

Shares of HUM stock opened at $360.84 on Friday. The firm has a fifty day moving average of $285.88 and a two-hundred day moving average of $241.60. The firm has a market cap of $43.32 billion, a P/E ratio of 38.59, a P/E/G ratio of 2.05 and a beta of 0.76. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $380.86. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. During the same quarter in the prior year, the business posted $11.58 EPS. The company’s revenue for the quarter was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, research analysts anticipate that Humana Inc. will post 9.04 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 annualized dividend and a yield of 1.0%. Humana’s dividend payout ratio is presently 37.86%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.